Aktie 000919 JINLING PHARMACEUTICAL COMPANY LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Jinling Pharmaceutical Company Limited

Aktien

000919

CNE0000010W5

000919

Schlusskurs Shenzhen S.E.
Andere Börsenplätze
 00:00:00 30.04.2024 		% 5 Tage % 1. Jan.
6.96 CNY +1.90% Intraday Chart für Jinling Pharmaceutical Company Limited +8.75% -11.56%
29.04. Jinling Pharmaceutical Company Limited meldet Ergebnis für das erste Quartal bis zum 31. März 2024 CI
18.04. Jinling Pharmaceutical Company Limited berichtet über die Ergebnisse für das am 31. Dezember 2023 endende Geschäftsjahr CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Jinling Pharmaceutical Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2024
Jinling Pharmaceutical Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023
Jinling Pharmaceutical Company Limited announced that it has received CNY 749.999998 million in funding from a group of investors
Jinling Pharma in Talks to Buy Over 50% Stake in Local Hospital
Jinling Pharmaceutical Company Limited agreed to acquire 43.6% stake in Nanjing Meishan Hospital Co., Ltd. from Nanjing New Industrial Investment Group Co.,Ltd. and Nanjing Zijin Investment Management Co., Ltd.
Jinling Pharmaceutical Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2023
Jinling Pharmaceutical Company Limited Reports Earnings Results for the Half Year Ended June 30, 2023
Jinling Pharma Selling 750 Million Yuan Shares to Fund New Projects
Jinling Pharmaceutical Company Limited Announces 2022 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on 14 July 2023
Jinling Pharmaceutical Company Limited Approves Management Appointments
Jinling Pharmaceutical Company Limited Approves Cash Dividend for the Year 2022
Jinling Pharmaceutical Vice Chairman Resigns
Jinling Pharmaceutical Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2023
Jinling Pharmaceutical Company Limited Proposes Final Cash Dividend for the Year 2022
Jinling Pharmaceutical Company Limited announced that it expects to receive CNY 750 million in funding from Nanjing New Industrial Investment Group Co., Ltd and other investors
Jinling Pharma Gets 155 Million Yuan Compensation for Office Demolition, Relocation
Jinling Pharmaceutical Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2022
Jinling Pharmaceutical Company Limited Reports Earnings Results for the Half Year Ended June 30, 2022
Jinling Pharmaceutical Company Limited Implements Final Profit Distribution for 2021, Payable on August 11, 2022
Jinling Pharmaceutical Company Limited Approves Cash Dividend for the Year 2021
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. 000919 Aktie
  4. Nachrichten Jinling Pharmaceutical Company Limited
  5. Andere Sprachen